Chromatin remodeler BAF maintains HBV cccDNA transcriptional competence and represents a therapeutic target
Nucleic Acids Research · 05.02.2026 · 54 (4)
DOI: 10.1093/nar/gkag073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 10.02.2026. Verfasst von Dan Huang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China. Hauptthemen laut MEDLINE: DNA, Circular, Hepatitis B virus, DNA, Viral, Chromatin Assembly and Disassembly. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Pearl River Talent Recruitment Program, National Natural Science Foundation of China, Wuhan Institute of Virology.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) persistence relies on the chromatin plasticity of covalently closed circular DNA (cccDNA), a viral minichromosome resistant to current therapies. Using proximity labeling (TurboID-dCas9), ChIP-seq and DNA pull-down assays, we identified SMARCC2—a BAF scaffolding subunit—bound to cccDNA enhancer-promoter regions (EnhⅠ/XP, CP/EnhII), where it sustains nucleosome-depleted regions (NDRs) and recruits RNA polymerase II. Genetic or pharmacological BAF inhibition compacted cccDNA chromatin, reduced histone acetylation (AcH3/AcH4), and enhanced SMC5/6-mediated silencing to suppress transcription, with the BAF ATPase inhibitor FHT-2344 reducing serum HBV DNA by 50% (P <.05) and intrahepatic HBV RNA by 70% (P <.01) without cccDNA loss, indicating epigenetic silencing. Mechanistically, BAF maintains NDRs by counteracting nucleosome retention and recruiting host transcription factors such as HNF4α. This work concludes that BAF safeguards cccDNA chromatin plasticity to enable viral persistence, and targeting BAF (e.g. FHT-2344) epigenetically silences cccDNA, offering a novel strategy for functional cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
- Medical School, University of Chinese Academy of Sciences, Beijing 100049, China.
- Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China.
- MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 51…
- Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China.
- Organ Transplant, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
ORCID-Profile: Dan Su, Xiaoying Fan, Xinwen Chen
Förderung
- The Pearl River Talent Recruitment Program
- National Natural Science Foundation of China
- Wuhan Institute of Virology
Zitieren
APA
Huang, D., Zheng, Y., Deng, E., Ji, X., Zhang, Y., Sun, H., Chen, Y., Yao, Y., Zhou, Y., Zhang, M., Zhou, Z., Chen, Y., Su, D., Fan, X., Chen, X., & Pei, R. (2026). Chromatin remodeler BAF maintains HBV cccDNA transcriptional competence and represents a therapeutic target. Nucleic Acids Research, 54(4). https://doi.org/10.1093/nar/gkag073
Vancouver
Huang D, Zheng Y, Deng E, Ji X, Zhang Y, Sun H, et al. Chromatin remodeler BAF maintains HBV cccDNA transcriptional competence and represents a therapeutic target. Nucleic Acids Research. 2026;54(4). doi:10.1093/nar/gkag073
BibTeX
@article{Huang2026,
author = {Huang, Dan and Zheng, Yi and Deng, Enze and Ji, Xinlei and Zhang, Yecheng and Sun, Hao and Chen, Yingshan and Yao, Yongxuan and Zhou, Yuan and Zhang, Mingxia and Zhou, Zhe and Chen, Yinghua and Su, Dan and Fan, Xiaoying and Chen, Xinwen and Pei, Rongjuan},
title = {Chromatin remodeler BAF maintains HBV cccDNA transcriptional competence and represents a therapeutic target},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {4},
doi = {10.1093/nar/gkag073}
}
EUVIMED